Interestingly, stereotactic radiotherapy (SBRT) has been suggested to increase the functionality of Tregs in the tumor microenvironment, in a TGF-β and IL33 independent manner pointing out the existence of multiple mechanisms involved in Tregs linked radioresistance (40). The gene discussed is TGFB1; the disease is neoplasm.